881 F.3d 1376 (2018)

MERCK SHARP & DOHME CORP., Plaintiff-Appellant v. AMNEAL PHARMACEUTICALS LLC, Defendant-Appellee.

United States Court of Appeals, Federal Circuit.

Decided: February 9, 2018.

Attorney(s) appearing for the Case

NICOLAS BARZOUKAS , Reed Smith LLP, Houston, TX, argued for plaintiff-appellant. Also represented by JOSHUA DAVIS , LISA M. THOMAS .

THOMAS J. MELORO , Willkie Farr & Gallagher LLP, New York, NY, argued for defendant-appellee. Also represented by DEVON EDWARDS , MATTHEW S. FREIMUTH , MICHAEL JOHNSON .

Before Taranto, Clevenger, and Stoll, Circuit Judges.

Merck Sharp & Dohme Corp. ("Merck") owns U.S. Patent No. 6,127,353, which claims mometasone furoate monohydrate, the active ingredient in Merck's Nasonex® nasal product. Amneal Pharmaceuticals LLC ("Amneal") submitted an Abbreviated New Drug Application ("ANDA") to the U.S. Food & Drug Administration ("FDA") seeking...

Let's get started

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases